cfDNA methylome profiling for detection and subtyping of small cell lung cancers Journal Article


Authors: Chemi, F.; Pearce, S. P.; Clipson, A.; Hill, S. M.; Conway, A. M.; Richardson, S. A.; Kamieniecka, K.; Caeser, R.; White, D. J.; Mohan, S.; Foy, V.; Simpson, K. L.; Galvin, M.; Frese, K. K.; Priest, L.; Egger, J.; Kerr, A.; Massion, P. P.; Poirier, J. T.; Brady, G.; Blackhall, F.; Rothwell, D. G.; Rudin, C. M.; Dive, C.
Article Title: cfDNA methylome profiling for detection and subtyping of small cell lung cancers
Abstract: Small cell lung cancer (SCLC) is characterized by morphologic, epigenetic and transcriptomic heterogeneity. Subtypes based upon predominant transcription factor expression have been defined that, in mouse models and cell lines, exhibit potential differential therapeutic vulnerabilities, with epigenetically distinct SCLC subtypes also described. The clinical relevance of these subtypes is unclear, due in part to challenges in obtaining tumor biopsies for reliable profiling. Here we describe a robust workflow for genome-wide DNA methylation profiling applied to both patient-derived models and to patients’ circulating cell-free DNA (cfDNA). Tumor-specific methylation patterns were readily detected in cfDNA samples from patients with SCLC and were correlated with survival outcomes. cfDNA methylation also discriminated between the transcription factor SCLC subtypes, a precedent for a liquid biopsy cfDNA-methylation approach to molecularly subtype SCLC. Our data reveal the potential clinical utility of cfDNA methylation profiling as a universally applicable liquid biopsy approach for the sensitive detection, monitoring and molecular subtyping of patients with SCLC. © 2022, The Author(s).
Journal Title: Nature Cancer
Volume: 3
Issue: 10
ISSN: 2662-1347
Publisher: Nature Research  
Date Published: 2022-10-01
Start Page: 1260
End Page: 1270
Language: English
DOI: 10.1038/s43018-022-00415-9
PUBMED: 35941262
PROVIDER: scopus
PMCID: PMC9586870
DOI/URL:
Notes: Article -- Export Date: 1 November 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charles Rudin
    495 Rudin
  2. Jacklynn V Egger
    69 Egger
  3. Rebecca Caeser
    14 Caeser